Bafna Pharmaceuticals informs about PCS certificate

11 Apr 2022 Evaluate
Bafna Pharmaceuticals has informed that it enclosed certificate from Practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the half year ended 31st March 2022.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharma Share Price

118.30 3.35 (2.91%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×